NEW YORK (GenomeWeb News) — Applied Imaging shareholders have approved the sale of the company to Genetix Group, AI said today.
 
As GenomeWeb News reported when the acquisition was announced in September, the all-cash deal is valued at $25.8 million. Genetix will pay $4.20 for each share of Applied Imaging's common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.